Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme – Data from a national neuro-oncology registry-Reference-Cited by-同舟云学术

Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme – Data from a national neuro-oncology registry

Published:2022-01 Issue: Volume:95 Page:142-150
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Hennessy Maeve A.,Coyne Zachary L.,O'Halloran Philip J.,Mullally William,Dablouk Mohamed,MacNally Stephen,Morris Patrick G.

Publisher

Elsevier BV

Subject

Physiology (medical),Neurology (clinical),Neurology,General Medicine,Surgery

Reference31 articles.

1. The epidemiology of glioma in adults: a “state of the science” review;Ostrom;Neuro Oncol,2014

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis;van Linde;J Neurooncol,2017

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

5. Standards of care for treatment of recurrent glioblastoma–are we there yet?;Weller;Neuro Oncol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of Glioblastoma;Anticancer Research;2024-06-26

2. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma;Radiation Oncology;2024-01-22

3. Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?;In Vivo;2024

4. Intraoperative radiotherapy in recurrent IDH-wildtype glioblastoma with gross total resection: A single-center retrospective study;Clinical Neurology and Neurosurgery;2024-01